Scientists have discovered a gut microbe and its metabolites that can naturally regulate blood sugar levels and sugar ...

The Trump administration this April scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...

A large study in older adults with type 2 diabetes finds that GLP-1 receptor agonists are associated with a modestly ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

Mounjaro is a prescription injection, often used off-label for weight loss, that is administered under the skin to patients struggling with obesity and weight loss. Off-label means that the actual use ...

The Cigna Group reported a strong start to the year, with first-quarter 2025 revenues rising 14% to $65.5 billion.

The results were the company's first since its March capital markets day, when it said it would grow top-line production and increase shareholder returns over the next five years. Cigna Group swung to ...

Novo Nordisk said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense race to get an oral weight-loss medication on the ...

A decision is expected in the fourth quarter of 2025.

Kyle Richards’ daughter Sophia Umansky detailed the unexpected side effects that surfaced four months after she started ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...